Ovarian Cancer Clinical Trial

Clinical Trial Finder Ovarian Cancer Trials

New Biomarkers Evaluating Ovarian Cancer

See Locations Near You

Summary

The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female, age 18 years or older
Adnexal mass present documented by imaging
Scheduled to undergo surgery based on a finding of adnexal mass
Able and willing to provide Informed Consent

Exclusion Criteria:

Previous history of ovarian cancer
Previous history of bilateral oophorectomy
Currently known to be pregnant
Unable to provide informed consent

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

280

Study ID:

NCT01466049

Recruitment Status:

Completed

Sponsor:

Fujirebio Diagnostics, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

New Hanover Regional Medical Center
Wilmington North Carolina, 28402, United States
University of Oklahoma
Oklahoma City Oklahoma, 73110, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

280

Study ID:

NCT01466049

Recruitment Status:

Completed

Sponsor:


Fujirebio Diagnostics, Inc.

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
Promising Immunotherapy Trials for Ovarian Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider